Swanridz Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 19-12-2024
- Paid Up Capital ₹ 1.00 M
as on 19-12-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
About Swanridz Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Alekha Nagendla and Badidala Srinivasarao serve as directors at the Company.
- CIN/LLPIN
U24299AP2020PTC114613
- Company No.
114613
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 May 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Guntur, Andhra Pradesh, India
- Telephone
- Email Address
- Social Media-
Who are the key members and board of directors at Swanridz Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alekha Nagendla  | Director | 23-Jul-2023 | Current |
| Badidala Srinivasarao | Director | 28-May-2020 | Current |
Financial Performance of Swanridz Pharma.
Enhance accessibility to Swanridz Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Swanridz Pharma?
Unlock access to Swanridz Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Dr.Madhav Pharma Private LimitedActive 4 years 6 monthsAlekha Nagendla and Badidala Srinivasarao are mutual person
- Svv Herbal And Nutraceuticals Private LimitedActive 3 months 15 days
Badidala Srinivasarao is a mutual person
- Srivaishnavi Micro Bio Lab Private LimitedActive 5 years 1 month
Badidala Srinivasarao is a mutual person
- Sri Acyuta Chit Funds Private LimitedActive 7 years 2 months
Badidala Srinivasarao is a mutual person
- Svayamjata Chit Funds Private LimitedActive 5 years 6 months
Badidala Srinivasarao is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Swanridz Pharma?
Swanridz Pharma has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Swanridz Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swanridz Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
